Back to results
US 2010/0136628 A1Published application
Novel OX40R Binding Agents
AssigneeMerck Serono SA
InventorsCLAUDIO SOTO-JARA, CLAUDIA PENA-ROSSI
Life of this patent
Estimating the term…
Abstract
The present invention discloses peptides isolated from the extracellular domain of OX40 Ligand (OX40L) capable of binding OX40 Receptor (OX40R) and inhibiting OX40R-OX40L interaction. Such peptides, fusion proteins comprising them, as well as peptides and other molecules designed on their sequences, can be used as OX40R binding agents competing with natural OX40L for blocking OX40R-mediated cell signaling in the prophylaxis and/or treatment of diseases related to activated T cells.
Claims16
An isolated nucleic acid encoding a polypeptide consisting of:
- a) SEQ ID NO:
- 6;
- b) SEQ ID NO:
- 6, wherein one or more amino acids have been deleted, said polypeptide contains SEQ ID NO:
- 13 and said polypeptide binds to the OX40 receptor (OX40R);
- c) between 5 and 10 contiguous amino acids of SEQ ID NO:
- 1, wherein said polypeptide contains SEQ ID NO:
- 13 and binds to OX40R;
- d) SEQ ID NO:
- 8 or SEQ ID NO:
- 13;
- e) an active mutant of a), b), c) or d), wherein one or more of the amino acids has been conservatively substituted and said active mutant binds to OX40R;
- or
- f) a fusion polypeptide or peptide comprising a first amino acid sequence and a second amino acid sequence, wherein said first amino acid sequence is a protein sequence other than human OX40L fused to a second amino acid sequence selected from:
- i) SEQ ID NO:
- 6;
- ii) SEQ ID NO:
- 6, wherein one or more amino acids have been deleted, said second amino acid sequence contains SEQ ID NO:
- 13 and said fusion polypeptide binds to the OX40 receptor (OX40R);
- iii) between 5 and 10 contiguous amino acids of SEQ ID NO:
- 1, wherein said contiguous amino acids of SEQ ID NO:
- 1 contain SEQ ID NO:
- 13 and said fusion polypeptide binds to OX40R;
- or
- iv) SEQ ID NO:
- 8 or SEQ ID NO:
- 13.
24 more elements
Dependencies are inferred from the claim text.